259 related articles for article (PubMed ID: 30622144)
1. Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response.
Nasri M; Mir P; Dannenmann B; Amend D; Skroblyn T; Xu Y; Schulze-Osthoff K; Klimiankou M; Welte K; Skokowa J
Blood Adv; 2019 Jan; 3(1):63-71. PubMed ID: 30622144
[TBL] [Abstract][Full Text] [Related]
2. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
[TBL] [Abstract][Full Text] [Related]
3. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
4. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
5. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
6. Gene Knockout in Hematopoietic Stem and Progenitor Cells Followed by Granulocytic Differentiation.
Mir P; Ritter M; Welte K; Skokowa J; Klimiankou M
Methods Mol Biol; 2020; 2115():455-469. PubMed ID: 32006417
[TBL] [Abstract][Full Text] [Related]
7. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
[TBL] [Abstract][Full Text] [Related]
8. TRIAMF: A New Method for Delivery of Cas9 Ribonucleoprotein Complex to Human Hematopoietic Stem Cells.
Yen J; Fiorino M; Liu Y; Paula S; Clarkson S; Quinn L; Tschantz WR; Klock H; Guo N; Russ C; Yu VWC; Mickanin C; Stevenson SC; Lee C; Yang Y
Sci Rep; 2018 Nov; 8(1):16304. PubMed ID: 30389991
[TBL] [Abstract][Full Text] [Related]
9. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie).
Perera OP; Little NS; Pierce CA
PLoS One; 2018; 13(5):e0197567. PubMed ID: 29771955
[TBL] [Abstract][Full Text] [Related]
11. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
Xu H; Kita Y; Bang U; Gee P; Hotta A
STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
[TBL] [Abstract][Full Text] [Related]
12. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
[TBL] [Abstract][Full Text] [Related]
13. Correction of Hemoglobin E/Beta-Thalassemia Patient-Derived iPSCs Using CRISPR/Cas9.
Wattanapanitch M
Methods Mol Biol; 2021; 2211():193-211. PubMed ID: 33336279
[TBL] [Abstract][Full Text] [Related]
14. Optimized Guide RNA Selection Improves
Verhagen HJMP; Kuijk C; Rutgers L; Kokke AM; van der Meulen SA; van Mierlo G; Voermans C; van den Akker E
CRISPR J; 2022 Oct; 5(5):702-716. PubMed ID: 36169633
[TBL] [Abstract][Full Text] [Related]
15. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
Bruntraeger M; Byrne M; Long K; Bassett AR
Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
[TBL] [Abstract][Full Text] [Related]
16. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
[TBL] [Abstract][Full Text] [Related]
17. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
Benetó N; Grinberg D; Vilageliu L; Canals I
Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
Petazzi P; Menéndez P; Sevilla A
Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
[TBL] [Abstract][Full Text] [Related]
19. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
[TBL] [Abstract][Full Text] [Related]
20. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]